Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deep vein thrombosis in a transgender woman.

Literature DB >> 28385895

Deep vein thrombosis in a transgender woman.

Wesley Chan¹, Alasdair Drummond¹, Martina Kelly².

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2017 PMID： 28385895 PMCID： PMC5378510 DOI： 10.1503/cmaj.160408

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

9 in total

1. Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.

Authors: T Baglin; K Bauer; J Douketis; H Buller; A Srivastava; G Johnson
Journal: J Thromb Haemost Date: 2012-04 Impact factor: 5.824

Review 2. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.

Authors: Alfonso Iorio; Clive Kearon; Esmeralda Filippucci; Maura Marcucci; Ana Macura; Vittorio Pengo; Sergio Siragusa; Gualtiero Palareti
Journal: Arch Intern Med Date: 2010-10-25

Review 3. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Authors: Marianne Canonico; Geneviève Plu-Bureau; Gordon D O Lowe; Pierre-Yves Scarabin
Journal: BMJ Date: 2008-05-20

Review 4. Safety of hormonal treatment in transgenders.

Authors: Maria Cristina Meriggiola; Marta Berra
Journal: Curr Opin Endocrinol Diabetes Obes Date: 2013-12 Impact factor: 3.243

Review 5. The controversy of managing calf vein thrombosis.

Authors: Elna M Masuda; Robert L Kistner; Chayanin Musikasinthorn; Fernando Liquido; Olga Geling; Qimei He
Journal: J Vasc Surg Date: 2011-10-26 Impact factor: 4.268

6. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors: Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal: Chest Date: 2016-01-07 Impact factor: 9.410

7. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.

Authors: Wylie C Hembree; Peggy Cohen-Kettenis; Henriette A Delemarre-van de Waal; Louis J Gooren; Walter J Meyer; Norman P Spack; Vin Tangpricha; Victor M Montori
Journal: J Clin Endocrinol Metab Date: 2009-06-09 Impact factor: 5.958

8. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City.

Authors: Nelson F Sanchez; John P Sanchez; Ann Danoff
Journal: Am J Public Health Date: 2009-01-15 Impact factor: 9.308

Review 9. Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.

Authors: H Asscheman; G T'Sjoen; A Lemaire; M Mas; M C Meriggiola; A Mueller; A Kuhn; C Dhejne; N Morel-Journel; L J Gooren
Journal: Andrologia Date: 2013-08-15 Impact factor: 2.775

9 in total

6 in total

Deep vein thrombosis in a transgender woman.

1. Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.

Review 2. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review.

Review 3. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Review 4. Safety of hormonal treatment in transgenders.

Review 5. The controversy of managing calf vein thrombosis.

6. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

7. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline.

8. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City.

Review 9. Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.

1. Adverse health outcomes in transgender people.

2. The authors respond to "Adverse health outcomes in transgender people".

Review 3. The Perioperative Care of the Transgender Patient.

Review 4. Considerations for Transgender Patients Perioperatively.

Review 5. Providing Care for Transgender Persons With Kidney Disease: A Narrative Review.

Review 6. Primary Sigmoid Vaginoplasty in Transwomen: Technique and Outcomes.